Guidelines for endoscopic and robotic breast surgery in China (2026 edition): Part one
- VernacularTitle:中国腔镜/机器人乳腺手术指南（2026版）：第一部分
- Author:
Zhenggui DU
1
;
Qing LÜ
1
;
Pengwei LÜ
2
;
Dajiang SONG
3
;
Zihan WANG
4
;
Benlong YANG
5
;
Shicheng SU
6
Author Information
1. Breast Disease Center of West China Hospital, Sichuan University, Chengdu, 610041, P. R. China
2. Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, P. R. China
3. Department of Oncologic Plastic Surgery, Hunan Cancer Hospital, Changsha, 410013, P. R. China
4. Department of Breast Surgery, Beijing Chao-yang Hospital, Capital Medical University, Beijing, 100020, P. R. China
5. Breast Surgery Department, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China
6. Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, P. R. China
- Collective Name:on behalf of the Chinese Endoscopic-robotic Breast Surgery Clinical Trials Consortium (CErBSCTC)
- Publication Type:Journal Article
- Keywords:
Breast cancer;
endoscopic surgery;
robotic surgery;
breast reconstruction;
perioperative management;
surgical standardization;
breast disease prevention and control;
guidelines
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2026;33(02):167-203
- CountryChina
- Language:Chinese
-
Abstract:
Recent research from the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO) indicates that breast cancer is the most prevalent malignant tumor among women, posing a significant threat to women's health. Surgery remains the primary therapeutic modality for breast cancer. Recently, endoscopic and robotic breast surgical techniques have gained acceptance among both surgeons and patients. However, considerable variation exists in surgical approaches and outcomes. To standardize these techniques, facilitate their broader clinical adoption, and ultimately improve patient care, the Endoscopic-robotic Breast Surgery Clinical Trials Consortium (ErBSCTC) of China has developed this guideline. This document encompasses the technologies and instrumentation utilized in endoscopic and robotic breast surgery, surgical techniques, perioperative management, complication handling, long-term follow-up, and oncologic outcomes, aiming to provide evidence-based guidance for healthcare professionals involved in the prevention, diagnosis, and treatment of breast diseases.
